The Patent Finder

Apeiron Biologics AG

15 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

4
Ending by 2030
Jun 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due May 12 to 17, 2027 · next May 12

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,716,833Method for producing ACE2 polypeptide
In force
 · USPTO record
In forceUSPTO record
US 8,809,288Method for increasing immunoreactivity
In force
 · USPTO record
In forceUSPTO record
US 8,586,319Recombinant ACE2 polypeptide dimer
In force
 · USPTO record
In forceUSPTO record
US 8,946,162Treatment of tumors
In force
 · USPTO record
In forceUSPTO record
US 9,561,263Treatment of inflammatory illnesses with ACE2
In force
 · USPTO record
In forceUSPTO record
US 9,186,373SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer
In force
 · USPTO record
In forceUSPTO record
US 9,777,068Method for Treating a GD2 Positive Cancer
In force
 · High confidence
In forceHigh confidence
US 9,840,566Preparations and Methods for Treating a GD2 Positive Cancer
In force
 · High confidence
In forceHigh confidence
US 10,294,305Method for Treating a GD2 Positive Cancer
In force
 · Low confidence
In forceLow confidence
US 11,447,565Method for Treating a GD2 Positive Cancer
In force
 · High confidence
In forceHigh confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
Also on record, not counted in the 15: 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited